260 related articles for article (PubMed ID: 34680110)
1. GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling.
Juin SK; Pushpakumar S; Sen U
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680110
[TBL] [Abstract][Full Text] [Related]
2. GYY4137, a Hydrogen Sulfide Donor Modulates miR194-Dependent Collagen Realignment in Diabetic Kidney.
John AMSP; Kundu S; Pushpakumar S; Fordham M; Weber G; Mukhopadhyay M; Sen U
Sci Rep; 2017 Sep; 7(1):10924. PubMed ID: 28883608
[TBL] [Abstract][Full Text] [Related]
3. MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.
Kundu S; Pushpakumar S; Sen U
Nitric Oxide; 2015 Apr; 46():172-85. PubMed ID: 25659756
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
Yu X; Li C; Li X; Cai L
Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
[TBL] [Abstract][Full Text] [Related]
5. An in vitro model for the pro-fibrotic effects of retinoids: mechanisms of action.
Rankin AC; Hendry BM; Corcoran JP; Xu Q
Br J Pharmacol; 2013 Nov; 170(6):1177-89. PubMed ID: 23992207
[TBL] [Abstract][Full Text] [Related]
6. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells.
Kooistra T; Lansink M; Arts J; Sitter T; Toet K
Eur J Biochem; 1995 Sep; 232(2):425-32. PubMed ID: 7556191
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulphide mitigates homocysteine-induced apoptosis and matrix remodelling in mesangial cells through Akt/FOXO1 signalling cascade.
Majumder S; Ren L; Pushpakumar S; Sen U
Cell Signal; 2019 Sep; 61():66-77. PubMed ID: 31085234
[TBL] [Abstract][Full Text] [Related]
8. Regulation of retinoid-mediated signaling involved in skin homeostasis by RAR and RXR agonists/antagonists in mouse skin.
Gericke J; Ittensohn J; Mihály J; Alvarez S; Alvarez R; Töröcsik D; de Lera AR; Rühl R
PLoS One; 2013; 8(4):e62643. PubMed ID: 23638129
[TBL] [Abstract][Full Text] [Related]
9. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9.
Kundu S; Pushpakumar SB; Tyagi A; Coley D; Sen U
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1365-78. PubMed ID: 23632630
[TBL] [Abstract][Full Text] [Related]
11. Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes.
Juin SK; Pushpakumar S; Tyagi SC; Sen U
Sci Rep; 2022 Dec; 12(1):21707. PubMed ID: 36522378
[TBL] [Abstract][Full Text] [Related]
12. A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy.
Huang Y; Border WA; Yu L; Zhang J; Lawrence DA; Noble NA
J Am Soc Nephrol; 2008 Feb; 19(2):329-38. PubMed ID: 18216319
[TBL] [Abstract][Full Text] [Related]
13. Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway.
Qiao S; Liu R; Lv C; Miao Y; Yue M; Tao Y; Wei Z; Xia Y; Dai Y
Free Radic Biol Med; 2019 Dec; 145():118-135. PubMed ID: 31494242
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
DiRenzo J; Söderstrom M; Kurokawa R; Ogliastro MH; Ricote M; Ingrey S; Hörlein A; Rosenfeld MG; Glass CK
Mol Cell Biol; 1997 Apr; 17(4):2166-76. PubMed ID: 9121466
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells.
Nicholas SB; Kawano Y; Wakino S; Collins AR; Hsueh WA
Hypertension; 2001 Feb; 37(2 Pt 2):722-7. PubMed ID: 11230363
[TBL] [Abstract][Full Text] [Related]
16. Collagen receptor- and metalloproteinase-dependent hypertensive stress response in mesangial and glomerular endothelial cells.
Majumder S; Amin M; Pushpakumar S; Sen U
Mol Cell Biochem; 2020 Mar; 466(1-2):1-15. PubMed ID: 31912277
[TBL] [Abstract][Full Text] [Related]
17. Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists.
Sharvit E; Abramovitch S; Reif S; Bruck R
PLoS One; 2013; 8(10):e76541. PubMed ID: 24098526
[TBL] [Abstract][Full Text] [Related]
18. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
20. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
